Early growth response genes regulate B cell development, proliferation, and immune response

被引:55
作者
Gururajan, Murali [1 ,2 ,3 ]
Simmons, Alan [1 ,2 ]
Dasu, Trivikram [1 ,2 ]
Spear, Brett T. [1 ,3 ,4 ]
Calulot, Christopher [1 ]
Robertson, Darrell A. [1 ,2 ]
Wiest, David L. [5 ]
Monroe, John G. [6 ]
Bondada, Subbarao [1 ,2 ,3 ,4 ]
机构
[1] Univ Kentucky, Dept Microbiol Immunol, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Mol Genet, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
[3] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA
[4] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA
[5] Fox Chase Canc Ctr, Div Basic Sci, Philadelphia, PA 19111 USA
[6] Hosp Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
D O I
10.4049/jimmunol.181.7.4590
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Egr-1 (early growth response gene-1) is an immediate early gene encoding a zinc finger motif-containing transcription factor. Upon cross-linking of BCR, mature B cells undergo proliferation with an increase in Egr-1 message. Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or by antisense oligonucleotides. To test the hypothesis that Egr-1 is important for B cell development, we examined B cells from primary and secondary lymphoid organs in Egr-l(-/-) mice. Marginal zone 13 cell development was arrested in these mice, whereas the B cells in all other compartments were increased. To test the hypothesis that Egr-1 function may be partially compensated by other Ear family members, we developed transgenic mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retains the DNA-binding domain, in a B cell-specific manner. There was a decrease in B lymphopoiesis in the bone marrow accompanied by a reduction in splenic immature and mature B cells as well as marginal zone B cells in the transgenic mice. Moreover, transgenic mice respond poorly to BCR cross-linking in vitro and T-independent and T-dependent Ags in vivo.
引用
收藏
页码:4590 / 4602
页数:13
相关论文
共 59 条
[1]   Impaired prostate tumorigenesis in Egr1-deficient mice [J].
Abdulkadir, SA ;
Qu, ZC ;
Garabedian, E ;
Song, SK ;
Peters, TJ ;
Svaren, J ;
Carbone, JM ;
Naughton, CK ;
Catalona, WJ ;
Ackerman, JJH ;
Gordon, JI ;
Humphrey, PA ;
Milbrandt, J .
NATURE MEDICINE, 2001, 7 (01) :101-107
[2]  
Adamson E, 2003, CANCER BIOL THER, V2, P617
[3]   Egr1 transcription factor: Multiple roles in prostate tumor cell growth and survival [J].
Adamson, ED ;
Mercola, D .
TUMOR BIOLOGY, 2002, 23 (02) :93-102
[4]   Peripheral B cell subsets [J].
Allman, David ;
Pillai, Shiv .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (02) :149-157
[5]  
Beckmann AM, 1997, NEUROCHEM INT, V31, P477, DOI 10.1016/S0197-0186(96)00136-2
[6]   Thymocyte development in early growth response gene 1-deficient mice [J].
Bettini, M ;
Xi, HK ;
Milbrandt, J ;
Kersh, GJ .
JOURNAL OF IMMUNOLOGY, 2002, 169 (04) :1713-1720
[7]   IDENTIFICATION AND CHARACTERIZATION OF THE EGR-1 GENE-PRODUCT, A DNA-BINDING ZINC FINGER PROTEIN-INDUCED BY DIFFERENTIATION AND GROWTH SIGNALS [J].
CAO, XM ;
KOSKI, RA ;
GASHLER, A ;
MCKIERNAN, M ;
MORRIS, CF ;
GAFFNEY, R ;
HAY, RV ;
SUKHATME, VP .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (05) :1931-1939
[8]   Early growth response transcription factors are required for development of CD4-CD8- thymocytes to the CD4+CD8+ stage [J].
Carleton, M ;
Haks, MC ;
Smeele, SAA ;
Jones, A ;
Belkowski, SM ;
Berger, MA ;
Linsley, P ;
Kruisbeek, AM ;
Wiest, DL .
JOURNAL OF IMMUNOLOGY, 2002, 168 (04) :1649-1658
[9]   THE EGR1 PROTEIN CONTAINS A DISCRETE TRANSCRIPTIONAL REGULATORY DOMAIN WHOSE DELETION RESULTS IN A TRUNCATED PROTEIN THAT BLOCKS EGR1-INDUCED TRANSCRIPTION [J].
CARMAN, JA ;
MONROE, JG .
DNA AND CELL BIOLOGY, 1995, 14 (07) :581-589
[10]   B cell receptor signal strength determines B cell fate [J].
Casola, S ;
Otipoby, KL ;
Alimzhanov, M ;
Humme, S ;
Uyttersprot, N ;
Kutok, JL ;
Carroll, MC ;
Rajewsky, K .
NATURE IMMUNOLOGY, 2004, 5 (03) :317-327